Sequencing the HUMAN EXOME is more cost effective than whole genome sequencing, and Novogene’s new Human Whole Exome Sequencing (hWES) promotion makes it even more viable, with access to all of Novogene’s advantages!
- PE150 Reads from Illumina Platform
- Validated Agilent SureSelect Human All Exon V6 Kit
- Data QC, Mapping, SNP / InDel Calling, Annotation, and Statistics, plus Somatic SNP / InDel / CNV (for Paired Tumor Samples) Analyses Available
- Data Output: 6Gb / Sample
- Only applicable for non-FFPE human samples
- Promotion valid for samples arriving before December 24th, 2019
* Only for research use in North and South America.
Get More Information
Novogene Corporation Inc.
Information and speciﬁcations are subject to change at any time without notice.